The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Open accessAbstract
Chemoresistance is a leading cause of morbidity and mortality in cancer and it continues to be a challenge in cancer treatment. Chemoresistance is influenced by genetic and epigenetic alterations which affect drug uptake, metabolism and export of drugs at the cellular levels. While most research has focused on tumor cell autonomous mechanisms of chemoresistance, the tumor microenvironment has emerged as a key player in the development of chemoresistance and in malignant progression, thereby influencing the development of novel therapies in clinical oncology. It is not surprising that the study of the tumor microenvironment is now considered to be as important as the study of tumor cells. Recent advances in technological and analytical methods, especially ‘omics’ technologies, has made it possible to identify specific targets in tumor cells and within the tumor microenvironment to eradicate cancer. Tumors need constant support from previously ‘unsupportive’ microenvironments. Novel therapeutic strategies that inhibit such microenvironmental support to tumor cells would reduce chemoresistance and tumor relapse. Such strategies can target stromal cells, proteins released by stromal cells and non-cellular components such as the extracellular matrix (ECM) within the tumor microenvironment. Novel in vitro tumor biology models that recapitulate the in vivo tumor microenvironment such as multicellular tumor spheroids, biomimetic scaffolds and tumor organoids are being developed and are increasing our understanding of cancer cell-microenvironment interactions. This review offers an analysis of recent developments on the role of the tumor microenvironment in the development of chemoresistance and the strategies to overcome microenvironment-mediated chemoresistance. We propose a systematic analysis of the relationship between tumor cells and their respective tumor microenvironments and our data show that, to survive, cancer cells interact closely with tumor microenvironment components such as mesenchymal stem cells and the extracellular matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X. H., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“The use of trastuzumab against the human epidermal growth factor receptor 2 (HER2), a protein involved in the development of breast cancer, was found to increase the efficacy of chemotherapy in metastatic breast cancer that overexpresses HER2 [263].”
BackgroundMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Matrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
Laminin–a glycoprotein from basement membranes
Timpl, R., Rohde, H., Robey, P. G., Rennard, S. I., Foidart, J. M., & Martin, G. R. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83607-4 · Cited by 2,378
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 1×
“Over time, cancer cells can acquire diverse strategies that decrease the efficacy of many therapeutic agents leading to chemoresistance [88].”
BackgroundPankov, R., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 1,953
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
Designer matrices for intestinal stem cell and organoid culture
Gjorevski, N., Sachs, N., Manfrin, A., Giger, S., Bragina, M. E., Ordóñez-Morán, P., Clevers, H., & Lutolf, M. P. (2016) · Nature · doi:10.1038/nature20168 · Cited by 1,426
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Acerbi, I., Cassereau, L., Dean, I., Shi, Q., Au, A., Park, C., Chen, Y. Y., Liphardt, J., Hwang, E. S., & Weaver, V. M. (2015) · Integrative Biology · doi:10.1039/c5ib00040h · Cited by 1,059
Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., Toyama, Y., Bonewald, L. F., & Kudo, A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1239 · Cited by 975
Tumor-associated macrophages: from basic research to clinical application
Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847
(2002) · PubMed · Cited by 840
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Gascard, P., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 732
Mechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Mechanisms of Drug Resistance in Cancer Chemotherapy
Luqmani, Y. A. (2005) · Medical Principles and Practice · doi:10.1159/000086183 · Cited by 651
Gillan, L., Matei, D. E., Fishman, D. A., Gerbin, C. S., Karlan, B. Y., & Chang, D. D. (2002) · PubMed · Cited by 629
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Park, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 586
Erdogan, B., & Webb, D. J. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160387 · Cited by 558
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Lipson, E. J., Sharfman, W. H., Drake, C. G., Wollner, I., Taube, J. M., Anders, R. A., Xu, H., Yao, S., Pons, A., Chen, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2625 · Cited by 545
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martín-Pérez, R., Serneels, J., Prenen, H., Ghesquière, B., Carmeliet, P., & Mazzone, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.008 · Cited by 496
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 487
The Tension Mounts: Mechanics Meets Morphogenesis and Malignancy
Paszek, M. J., & Weaver, V. M. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1404-x · Cited by 467
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Chang, A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.022 · Cited by 443
Matrix stiffening promotes a tumor vasculature phenotype
Bordeleau, F., Mason, B. N., Lollis, E. M., Mazzola, M., Zanotelli, M. R., Somasegar, S., Califano, J. P., Montague, C., LaValley, D. J., Huynh, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613855114 · Cited by 416
Miroshnikova, Y. A., Mouw, J. K., Barnes, J. M., Pickup, M. W., Lakins, J. N., Kim, Y., Lobo, K., Persson, A. I., Reis, G. F., McKnight, T. R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3429 · Cited by 383
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Afik, R., Zigmond, E., Vugman, M., Klepfish, M., Shimshoni, E., Pasmanik-Chor, M., Shenoy, A., Bassat, E., Halpern, Z., Geiger, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151193 · Cited by 375
Semenza, G. L. (2017) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 366
Tumor acidity, ion trapping and chemotherapeutics
Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00467-2 · Cited by 364
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 342
Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies
Philips, G. K., & Atkins, M. (2015) · International Immunology · doi:10.1093/intimm/dxu095 · Cited by 335
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
Conze, D. B., Weiss, L., Regen, P. S., Bhushan, A., Weaver, D. L., Johnson, P. F., & Rincón, M. (2001) · PubMed · Cited by 334
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
Armstrong, T., Packham, G., Murphy, L. B., Bateman, A. C., Conti, J. A., Fine, D. R., Johnson, C. D., Benyon, R. C., & Iredale, J. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0825 · Cited by 317
Kass, L., Erler, J. T., Dembo, M., & Weaver, V. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.025 · Cited by 309
Roodhart, J. M. L., Daenen, L. G. M., Stigter, E. C. A., Prins, H.-J., Gerrits, J., Houthuijzen, J. M., Gerritsen, M. G., Schipper, H. S., Backer, M. J. G., van Amersfoort, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.010 · Cited by 305
BISSELL, M. J., KENNY, P. A., & RADISKY, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.013 · Cited by 298
Wang, W., Li, Q., Yamada, T., Matsumoto, K., Matsumoto, I., Oda, M., Watanabe, G., Kayano, Y., Nishioka, Y., Sone, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1001 · Cited by 297
Zhou, H., Fan, Z., Deng, J., Lemons, P. K., Arhontoulis, D. C., Bowne, W. B., & Cheng, H. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00820 · Cited by 293
Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., Takeyama, H., Tong, Z., & Guha, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24040 · Cited by 279
Guryanova, O. A., Shank, K., Spitzer, B., Luciani, L., Koche, R. P., Garrett-Bakelman, F. E., Ganzel, C., Durham, B. H., Mohanty, A., Hoermann, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4210 · Cited by 256
Abdel-Qadir, H., Ethier, J.-L., Lee, D. S., Thavendiranathan, P., & Amir, E. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.002 · Cited by 251
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
Saunders, N. A., Simpson, F., Thompson, E. W., Hill, M. M., Endo‐Munoz, L., Leggatt, G., Minchin, R. F., & Guminski, A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101131 · Cited by 249
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
Bioprinting the Cancer Microenvironment
Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00246 · Cited by 248
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta-Grigoriou, F. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 240
Cycling hypoxia: A key feature of the tumor microenvironment
Michiels, C., Tellier, C., & Feron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 237
Bharti, R., Dey, G., & Mandal, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.048 · Cited by 228
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
Brechbuhl, H. M., Finlay-Schultz, J., Yamamoto, T. M., Gillen, A. E., Cittelly, D. M., Tan, A.-C., Sams, S. B., Pillai, M. M., Elias, A. D., Robinson, W. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2851 · Cited by 228
Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look
Whatcott, C. J., Han, H., Posner, R. G., Hostetter, G., & Von Hoff, D. D. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0136 · Cited by 223
Extracellular Matrix, a Hard Player in Angiogenesis
Mongiat, M., Andreuzzi, E., Tarticchio, G., & Paulitti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111822 · Cited by 223
COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer
Wu, Y.-H., Chang, T.-H., Huang, Y.-F., Huang, H.-D., & Chou, C.-Y. (2014) · Oncogene · doi:10.1038/onc.2013.307 · Cited by 220
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2678 · Cited by 219
In vitro cancer cell–ECM interactions inform in vivo cancer treatment
Holle, A. W., Young, J. L., & Spatz, J. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.007 · Cited by 213
Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression
Shields, M. A., Dangi-Garimella, S., Redig, A. J., & Munshi, H. G. (2012) · Biochemical Journal · doi:10.1042/bj20111240 · Cited by 205
Levitt, N. S., Steyn, K., Dave, J., & Bradshaw, D. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.019075 · Cited by 205
Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes
Mehta, R. S., Song, M., Nishihara, R., Drew, D. A., Wu, K., Qian, Z. R., Fung, T. T., Hamada, T., Masugi, Y., da Silva, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.015 · Cited by 203
Directed migration of cancer cells guided by the graded texture of the underlying matrix
Park, J., Kim, D.-H., Kim, H.-N., Wang, C. J., Kwak, M. K., Hur, E., Suh, K.-Y., An, S. S., & Levchenko, A. (2016) · Nature Materials · doi:10.1038/nmat4586 · Cited by 201
Ahmadzadeh, H., Webster, M. R., Behera, R., Jimenez Valencia, A. M., Wirtz, D., Weeraratna, A. T., & Shenoy, V. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617037114 · Cited by 191
Fibronectin-guided migration of carcinoma collectives
Gopal, S., Veracini, L., Grall, D., Butori, C., Schaub, S., Audebert, S., Camoin, L., Baudelet, E., Radwanska, A., Beghelli-de la Forest Divonne, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14105 · Cited by 189
Underwood, T. J., Hayden, A. L., Derouet, M., Garcia, E., Noble, F., White, M. J., Thirdborough, S., Mead, A., Clemons, N., Mellone, M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4467 · Cited by 186
Szebeni, G. J., Vizler, C., Kitajka, K., & Puskas, L. G. (2017) · Mediators of Inflammation · doi:10.1155/2017/9294018 · Cited by 184
Drug resistance and the microenvironment: nature and nurture
Morin, P. J. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00059-1 · Cited by 182
Parodi, A., Haddix, S. G., Taghipour, N., Scaria, S., Taraballi, F., Cevenini, A., Yazdi, I. K., Corbo, C., Palomba, R., Khaled, S. Z., et al. (2014) · ACS Nano · doi:10.1021/nn502807n · Cited by 181
Januchowski, R., Świerczewska, M., Sterzyńska, K., Wojtowicz, K., Nowicki, M., & Zabel, M. (2016) · Journal of Cancer · doi:10.7150/jca.15371 · Cited by 179
Pinto, M. L., Rios, E., Silva, A. C., Neves, S. C., Caires, H. R., Pinto, A. T., Durães, C., Carvalho, F. A., Cardoso, A. P., Santos, N. C., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.004 · Cited by 179
Mechanism of Cell Adaptation: When and How Do Cancer Cells Develop Chemoresistance?
Fodale, V., Pierobon, M., Liotta, L., & Petricoin, E. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e318212dd3d · Cited by 175
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 175
Microenvironment drug resistance in multiple myeloma: emerging new players
Di Marzo, L., Desantis, V., Solimando, A. G., Ruggieri, S., Annese, T., Nico, B., Fumarulo, R., Vacca, A., & Frassanito, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.10849 · Cited by 173
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
Houthuijzen, J. M., Daenen, L. G. M., Roodhart, J. M. L., & Voest, E. E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.201 · Cited by 172
Chemoresistance in solid tumours
Wilson, T. R., Longley, D. B., & Johnston, P. G. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl280 · Cited by 170
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR
Nieponice, A., McGrath, K., Qureshi, I., Beckman, E. J., Luketich, J. D., Gilbert, T. W., & Badylak, S. F. (2009) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.04.022 · Cited by 170
The Microenvironment of Lung Cancer and Therapeutic Implications
Mittal, V., Rayes, T. E., Narula, N., McGraw, T. E., Altorki, N. K., & Barcellos‐Hoff, M. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_5 · Cited by 170
Genomic evolution and chemoresistance in germ-cell tumours
Taylor-Weiner, A., Zack, T., O’Donnell, E., Guerriero, J. L., Bernard, B., Reddy, A., Han, G. C., AlDubayan, S., Amin-Mansour, A., Schumacher, S. E., et al. (2016) · Nature · doi:10.1038/nature20596 · Cited by 170
Brown, D. V., Filiz, G., Daniel, P. M., Hollande, F., Dworkin, S., Amiridis, S., Kountouri, N., Ng, W., Morokoff, A. P., & Mantamadiotis, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172791 · Cited by 167
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Dauer, P., Nomura, A., Saluja, A., & Banerjee, S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.12.010 · Cited by 165
From transformation to metastasis: deconstructing the extracellular matrix in breast cancer
Kaushik, S., Pickup, M. W., & Weaver, V. M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9650-0 · Cited by 162
Gomez-Chou, S. B., Swidnicka-Siergiejko, A. K., Badi, N., Chavez-Tomar, M., Lesinski, G. B., Bekaii-Saab, T., Farren, M. R., Mace, T. A., Schmidt, C., Liu, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1986 · Cited by 162
Kalaszczynska, I., & Ferdyn, K. (2015) · BioMed Research International · doi:10.1155/2015/430847 · Cited by 161
Oncogenic regulation of tumor metabolic reprogramming
Tarrado-Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 161
Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M. B., Brashears, C. B., Radyk, M. D., Redlich, N., Tzeng, S.-C., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 159
Wu, H., Zhiyong, L., Xiaohua, S., Xinyu, R., Wang, K., & Tonghua, L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-125 · Cited by 157
Tumor angiogenesis—characteristics of tumor endothelial cells
Hida, K., Maishi, N., Torii, C., & Hida, Y. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-0957-1 · Cited by 156
Lee, S., Han, H., Koo, H., Na, J. H., Yoon, H. Y., Lee, K. E., Lee, H., Kim, H., Kwon, I. C., & Kim, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.035 · Cited by 154
The Regulation of Cellular Responses to Mechanical Cues by Rho GTPases
Hoon, J.-L., Tan, M., & Koh, C.-G. (2016) · Cells · doi:10.3390/cells5020017 · Cited by 153
Zhai, W., Lim, T. K. H., Zhang, T., Phang, S.-T., Tiang, Z., Guan, P., Ng, M.-H., Lim, J. Q., Yao, F., Li, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14565 · Cited by 151
Vaupel, P. W., & Mayer, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0620-8_3 · Cited by 147
Avnet, S., Pompo, G. D., Chano, T., Errani, C., Ibrahim‐Hashim, A., Gillies, R. J., Donati, D. M., & Baldini, N. (2016) · International Journal of Cancer · doi:10.1002/ijc.30540 · Cited by 147
Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
Kosmehl, H., Berndt, A., Strassburger, S., Borsi, L., Rousselle, P., Mandel, U., Hyckel, P., Zardi, L., & Katenkamp, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690809 · Cited by 145
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
Sato, N., Kohi, S., Hirata, K., & Goggins, M. (2016) · Cancer Science · doi:10.1111/cas.12913 · Cited by 145
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y., den Eynde, K. V., den broeck, A. V., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 144
Barcus, C. E., O’Leary, K. A., Brockman, J. L., Rugowski, D. E., Liu, Y., Garcia, N., Yu, M., Keely, P. J., Eliceiri, K. W., & Schuler, L. A. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0801-1 · Cited by 141
Schwartz, L. H., Seyfried, T. N., Alfarouk, K. O., Moreira, J. D. V., & Fais, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.005 · Cited by 140
Cell adhesion and drug resistance in cancer
Croix, B. S., & Kerbel, R. S. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00010 · Cited by 138
Shin, J., & Mooney, D. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611338113 · Cited by 138
Cao, Z., Scandura, J. M., Inghirami, G., Shido, K., Ding, B., & Rafii, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.010 · Cited by 138
Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance
Lee, G., Hall, R. R., & Ahmed, A. U. (2016) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000363 · Cited by 129
Romero-López, M., Trinh, A. L., Sobrino, A., Hatch, M. M. S., Keating, M. T., Fimbres, C., Lewis, D. E., Gershon, P. D., Botvinick, E. L., Digman, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.034 · Cited by 125
Tsurutani, J., West, K. A., Sayyah, J., Gills, J. J., & Dennis, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0058 · Cited by 120
Tensile Forces Originating from Cancer Spheroids Facilitate Tumor Invasion
Kopanska, K. S., Alcheikh, Y., Staneva, R., Vignjevic, D. M., & Betz, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156442 · Cited by 118
Song, Y., Kim, S.-H., Kim, K. M., Choi, E. K., Kim, J., & Seo, H. R. (2016) · Scientific Reports · doi:10.1038/srep36750 · Cited by 117
Chong, I., Chang, M., Chang, H., Yu, Y., Sheu, C., Tsai, J., Hung, J., Chou, S., Tsai, M.-S., Hwang, J., et al. (2006) · Oncology Reports · doi:10.3892/or.16.5.981 · Cited by 116
Xing, H., Weng, D., Chen, G., Tao, W., Zhu, T., Yang, X., Li, M., Wang, S., Lu, Y., & Ma, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.022 · Cited by 116
Beyond the Oncogene Paradigm: Understanding Complexity in Cancerogenesis
Bizzarri, M., Cucina, A., Conti, F., & D’Anselmi, F. (2008) · Acta Biotheoretica · doi:10.1007/s10441-008-9047-8 · Cited by 115
Extracellular matrix regulation of drug resistance in small-cell lung cancer
Rintoul, R. C., & Sethi, T. (2002) · Clinical Science · doi:10.1042/cs1020417 · Cited by 115
Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115
Mellone, M., Hanley, C. J., Thirdborough, S., Mellows, T., Garcia, E., Woo, J., Tod, J., Frampton, S., Jenei, V., Moutasim, K. A., et al. (2016) · Aging · doi:10.18632/aging.101127 · Cited by 114
Lee, C. M., & Tannock, I. F. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603010 · Cited by 113
Wu, Y., Chang, T., Huang, Y.-F., Chen, C., & Chou, C.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4250 · Cited by 113
Guerra, L., Odorisio, T., Zambruno, G., & Castiglia, D. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.01.002 · Cited by 113
Periostin promotes ovarian cancer angiogenesis and metastasis
Zhu, M., Fejzo, M. S., Anderson, L. A., Dering, J., Ginther, C., Ramos, L., Gasson, J. C., Karlan, B. Y., & Slamon, D. J. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.07.008 · Cited by 109
Tumor Microenvironment Promotes Cancer Progression, Metastasis, and Therapeutic Resistance
Sung, S., Hsieh, C., Wu, D., Chung, L. W. K., & Johnstone, P. A. S. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2006.12.002 · Cited by 106
Januchowski, R., Zawierucha, P., Ruciński, M., Nowicki, M. O., & Zabel, M. (2014) · BioMed Research International · doi:10.1155/2014/365867 · Cited by 106
Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment
Wong, P., Bodrug, N., & Hodivala‐Dilke, K. (2016) · Current Biology · doi:10.1016/j.cub.2016.09.043 · Cited by 106
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 102
Cortini, M., Massa, A., Avnet, S., Bonuccelli, G., & Baldini, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166500 · Cited by 102
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
Luna, J. I., Grossenbacher, S. K., Murphy, W. J., & Canter, R. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1271874 · Cited by 100
Li, J. Z., Wood, W. H., Becker, K. G., Weeraratna, A. T., & Morin, P. J. (2006) · Oncogene · doi:10.1038/sj.onc.1210086 · Cited by 98
Grantab, R., & Tannock, I. F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-214 · Cited by 94
Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma
Berchtold, S., Grünwald, B. T., Krüger, A., Reithmeier, A., Hähl, T., Cheng, T., Feuchtinger, A., Born, D., Erkan, M., Kleeff, J. H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.020 · Cited by 94
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
Abulaiti, A., Shintani, Y., Funaki, S., Nakagiri, T., Inoue, M., Sawabata, N., Minami, M., & Okumura, M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.008 · Cited by 92
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells
Mumenthaler, S. M., Foo, J., Choi, N. C., Heise, N., Leder, K., Agus, D. B., Pao, W. J., Michor, F., & Mallick, P. (2015) · Cancer Informatics · doi:10.4137/cin.s19338 · Cited by 92
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
Veirman, K. D., Rao, L., Bruyne, E. D., Menu, E., Valckenborgh, E. V., Riet, I. V., Frassanito, M. A., Marzo, L. D., Vacca, A., & Vanderkerken, K. (2014) · Cancers · doi:10.3390/cancers6031363 · Cited by 89
Cui, L., Tse, K. C. K., Zahedi, P., Harding, S. M., Zafarana, G., Jaffray, D. A., Bristow, R. G., & Allen, C. J. (2014) · Radiation Research · doi:10.1667/rr13642.1 · Cited by 86
Sung, P., Jan, Y., Lin, S., Huang, C.-C., Lin, H., Wen, K., Chao, K.-C., Lai, C., Wang, P., Chuang, C.-M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6700 · Cited by 86
Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis
Ribatti, D. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.041 · Cited by 84
Extracellular matrix as target for antitumor therapy
Jeney, A., & Harisi, R. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s48883 · Cited by 83
Dangi-Garimella, S. Y., Sahai, V., Ebine, K., Kumar, K., & Munshi, H. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064566 · Cited by 83
Zhang, H., Xie, C., Yue, J., Jiang, Z., Zhou, R., Xie, R., Wang, Y., & Wu, S. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22581 · Cited by 83
Targeting therapy-resistant cancer stem cells by hyperthermia
Oei, A. L., Vriend, L. E. M., Krawczyk, P. M., Horsman, M. R., Franken, N. A. P., & Crezee, J. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1279757 · Cited by 83
Chen, J., Lu, L., Feng, Y., Wang, H., Dai, L., Li, Y., & Zhang, P. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.005 · Cited by 82
Metastatic State of Cancer Cells May Be Indicated by Adhesion Strength
Fuhrmann, A., Banisadr, A., Beri, P., Tlsty, T. D., & Engler, A. J. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2016.12.038 · Cited by 82
Role of RPL39 in Metaplastic Breast Cancer
Dave, B., Gonzalez, D. D., Zhi-Bin, L., Li, X., Wong, H. H., Granados-Principal, S. M., Ezzedine, N. E., Sieglaff, D. H., Ensor, J., Miller, K. D., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw292 · Cited by 81
The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymes
Binder, M. J., McCoombe, S. G., Williams, E. D., McCulloch, D. R., & Ward, A. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.001 · Cited by 80
Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space
Chen, Y., Guo, H., Terajima, M., Banerjee, P., Liu, X., Jiang, Y. L., Momin, A. A., Katayama, H., Hanash, S., Burns, A. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759803 · Cited by 79
TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells
Wu, X., Wu, M., Jiang, M., Zhi, Q., Bian, X., Xu, M., Gong, F.-R., Hou, J., Tao, M., Shou, L., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0382-1 · Cited by 77
Nordby, Y., Richardsen, E. H., Rakaee, M., Ness, N., Dønnem, T., Patel, H., Busund, L., Bremnes, R. M., & Andersen, S. (2017) · Scientific Reports · doi:10.1038/srep43378 · Cited by 76
İşeri, Ö. D., Kars, M. D., Arpacı, F., & Gündüz, U. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1048-z · Cited by 75
Han, S., Sidell, N., Roser‐Page, S., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20281 · Cited by 75
Roles of Metalloproteases in Metastatic Niche
Rucci, N., Sanità, P., & Angelucci, A. (2011) · Current Molecular Medicine · doi:10.2174/156652411797536705 · Cited by 75
Chen, L., Oh, D., Ryu, M., Yeh, K., Yeo, W., Carlesi, R. M., Cheng, R., Kim, J.-S., Orlando, M., & Kang, Y. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.176 · Cited by 75
Breast tumor stroma: A driving force in the development of resistance to therapies
Majidinia, M., & Yousefi, B. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12893 · Cited by 71
Fink, K., & Boratyński, J. (2012) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1009705 · Cited by 70
Zhang, C., Cao, S., Toole, B. P., & Xu, Y. (2014) · International Journal of Cancer · doi:10.1002/ijc.28975 · Cited by 70
Tumbarello, D. A., Temple, J., & Brenton, J. D. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-36 · Cited by 70
Parajuli, H., Teh, M., Abrahamsen, S., Christoffersen, I., Neppelberg, E., Lybak, S., Osman, T., Johannessen, A. C., Gullberg, D., Skarstein, K., et al. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12493 · Cited by 70
Saber, M. M., Bahrainian, S., Dinarvand, R., & Atyabi, F. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.016 · Cited by 70
Torok, S., Rezeli, M., Kelemen, O., Vegvari, A., Watanabe, K., Sugihara, Y., Tisza, A., Marton, T., Kovacs, I., Tovari, J., et al. (2017) · Theranostics · doi:10.7150/thno.16767 · Cited by 70
Spitschak, A., Meier, C., Kowtharapu, B. S., Engelmann, D., & Pützer, B. M. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0563-x · Cited by 69
Teng, P.-N., Wang, G., Hood, B. L., Conrads, K. A., Hamilton, C. A., Maxwell, G. L., Darcy, K. M., & Conrads, T. P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.687 · Cited by 66
Barcus, C. E., Holt, E. C., Keely, P. J., Eliceiri, K. W., & Schuler, L. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116891 · Cited by 66
Han, S., Sidell, N., & ROMAN, J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.040 · Cited by 65
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis
Jahani, M., Azadbakht, M., Norooznezhad, F., & Mansouri, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.047 · Cited by 65
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
Simone, V. D., Brunetti, O., Lupo, L., Testini, M., Maiorano, E., Simone, M. D., Longo, V., Rolfo, C. D., Peeters, M., Scarpa, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020418 · Cited by 65
Kerbel, R. S., Rak, J., Kobayashi, H., Man, M. S., Croix, B. S., & Ch, G. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.076 · Cited by 64
Vessel pruning or healing: endothelial metabolism as a novel target?
Cantelmo, A. R., Pircher, A., Kalucka, J. M., & Carmeliet, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1282465 · Cited by 64
Pasquereau-Kotula, E., Berthault, N., Agrario, C., Lienafa, M.-C., Simon, A., Dingli, F., Loew, D., Sibut, V., Saule, S., & Dutreix, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026522 · Cited by 62
Seebacher, N. A., Lane, D. J. R., Jansson, P. J., & Richardson, D. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682450 · Cited by 61
Haldorsen, I. S., Stefansson, I. M., Grüner, R., Husby, J. A., Magnussen, I. J., Werner, H. M. J., Salvesen, Ø. O., Bjørge, L., Trovik, J., Taxt, T., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.694 · Cited by 60
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity
Fujimura, T., Kakizaki, A., Furudate, S., Kambayashi, Y., & Aiba, S. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.05.015 · Cited by 60
Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer
Yang, L., Li, F., Gao, F., Xing, L., Qin, P., Liang, X., Zhang, J., Qiao, X.-H., Lin, L., Zhao, Q., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5321-6 · Cited by 60
Molecular Pathways: Mucins and Drug Delivery in Cancer
Rao, C. V., Janakiram, N. B., & Mohammed, A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0862 · Cited by 60
Dzobo, K., Senthebane, D. A., Rowe, A., Thomford, N. E., Mwapagha, L. M., Al-Awwad, N., Dandara, C., & Parker, M. I. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0152 · Cited by 59
Self-citationStromal factors involved in human prostate cancer development, progression and castration resistance
Eiró, N., Gómez, J. M. F., Sacristán, R., Fernández‐García, B., Lobo, B., Gonzalez-Suarez, J., Quintas, A., Escaf, S., & Vizoso, F. J. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2284-3 · Cited by 58
Ortiz, R. J., Díaz, J., Díaz‐Valdivia, N., Lobos‐González, L., Cárdenas, A., Contreras, P., Díaz, M. I., Otte, E. A., Cooper-White, J. J., Torres, V. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9738 · Cited by 57
Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis
Lü, Y., Yu, S., Zong, M., Fan, S., Lu, T.-B., Gong, R., Sun, L., & Fan, L. (2017) · Scientific Reports · doi:10.1038/srep40274 · Cited by 57
Hui, L., Zhang, J., Ding, X., Guo, X., & Jiang, X. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3877 · Cited by 56
Genetic and epigenetic stability of oligodendrogliomas at recurrence
Aihara, K., Mukasa, A., Nagae, G., Nomura, M., Yamamoto, S., Ueda, H., Tatsuno, K., Shibahara, J., Takahashi, M., Momose, T., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0422-z · Cited by 55
Laminin-5 offsets the efficacy of gefitinib (‘Iressa’) in hepatocellular carcinoma cells
Giannelli, G., Azzariti, A., Fransvea, E., Porcelli, L., Antonaci, S., & Paradiso, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602231 · Cited by 54
Fibroblasts, an inconspicuous but essential player in colon cancer development and progression
Mukaida, N., & Sasaki, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i23.5301 · Cited by 54
Yang, Z., Sun, Y., Xu, X., et al. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001587 · Cited by 54
The Role of Prophylactic Surgery in Cancer Prevention
You, Y. N., Lakhani, V. T., & Wells, S. A. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0616-1 · Cited by 53
Zhang, K., Li, P., He, Y., Bo, X., Li, X., Li, D., Chen, H., & Xu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.014 · Cited by 53
Lee, J. S., Yoo, J. E., Kim, H., Rhee, H., Koh, M. J., Nahm, J. H., Choi, J. S., Lee, K.-H., & Park, Y. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171922 · Cited by 53
Ikeda, Y., Hisano, H., Nishikawa, Y., & Nagasaki, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00011 · Cited by 52
Maturu, P., Jones, D., Ruteshouser, E. C., Hu, Q., Reynolds, J. M., Hicks, J. M., Putluri, N., Ekmekçioglu, S., Grimm, E. A., Dong, C., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2016.07.009 · Cited by 52
Zhang, Y., Xu, Y. Y., Ma, J., Pang, X., & Dong, M. (2017) · Scientific Reports · doi:10.1038/srep40524 · Cited by 49
Complexity in cancer stem cells and tumor evolution: Toward precision medicine
Porta, C. A. M. L., & Zapperi, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.007 · Cited by 49
Lu, Y., Ji, N., Wei, W., Sun, W., Gong, X., & Wang, X. (2017) · Biology Open · doi:10.1242/bio.021774 · Cited by 48
Guo, P., Wang, S., Liang, W. H., Wang, W., Wang, H., Zhao, M., & Liu, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6049 · Cited by 47
Cramer, G. M., Jones, D. P., El-Hamidi, H., & Celli, J. P. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0260 · Cited by 45
Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies
Riechelmann, R. P., & Grothey, A. F. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016676703 · Cited by 43
Fibroblast activation and senescence in oral cancer
Prime, S. S., Cirillo, N., Hassona, Y. M., Lambert, D., Paterson, I. C., Mellone, M., Thomas, G. J., James, E. N., & Parkinson, E. K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12456 · Cited by 42
Lim, E.-J., Suh, Y., Yoo, K.-C., Lee, J.-H., Kim, I. G., Kim, M.-J., Chang, J. H., Kang, S., & Lee, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13638 · Cited by 42
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Qin, X., Guo, H., Wang, X., Zhu, X., Yan, M., Wang, X., Xu, Q., Shi, J., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 431
Metadata
- Authors
- Senthebane, D. A., Rowe, A., Thomford, N. E., Shipanga, H., Munro, D., Mazeedi, M. A. M. A., Almazyadi, H. A. M., Kallmeyer, K., Dandara, C., Pepper, M. S., Parker, M. I., & Dzobo, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-07-21
- Volume
- 18
- Issue
- 7
- Pages
- 1586
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2738462696
- Cited by
- 399
- References
- 256
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.